ArticleFrontiers in aging neuroscience2026
A deep residual attention-Recurrent model for early and multi-stage Alzheimer's disease detection.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alzheimer's disease (AD) is a progressive neurodegenerative disorder that requires accurate and early diagnosis. Deep learning methods have shown significant potential for automated MRI-based AD classification. Methods: A hybrid deep learning framework integrating ResNet152V2, Convolutional Block Attention Module (CBAM), and Bidirectional Gated Recurrent Unit (Bi-GRU) was developed for three-class classification of Normal Cognition (NC), Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD). The model was trained using 2,100 ADNI subjects and externally validated using 900 OASIS subjects. Results: The proposed framework achieved 94.5% classification accuracy with an AUC of 95.0% on the ADNI dataset and 92.8% accuracy on the OASIS dataset. Comparative analyses demonstrated improvements of 5.2-7.0% over baseline models. Ablation studies confirmed the contribution of CBAM and Bi-GRU to overall performance. Discussion: The integration of deep residual feature extraction, attention-based refinement, and sequential modeling effectively captures disease-related anatomical patterns. The results suggest that the proposed framework may support automated multi-stage Alzheimer's disease classification and provide a foundation for future computer-aided diagnostic systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.